DOI:
10.1055/s-00034915
Onkologische Welt
LinksClose Window
References
André T. et al
Pembrolizumab versus chemotherapy for microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 study..
ASCO 2020 Abstract LBA4
Access:
We do not assume any responsibility for the contents of the web pages of other providers.